Colposcopy Market Size, Share & Trends Analysis Report By Modality (Optical, Video), By Application (Pelvic, Oral), By Portability, By End-use, By Region, And Segment Forecasts, 2023 - 2030

Report Overview

The global colposcopy market size was estimated at USD 522.2 million in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 4.4% from 2023 to 2030. Factors such as the rise in the prevalence of cervical cancer and the high demand for early diagnostic techniques are expected to boost the market growth. According to the reports published by the World Health Organization, cervical cancer is the fourth most common cancer among women globally. Moreover, according to a statistics report by the American Cancer Society, in 2023, about 13,960 estimated cases of invasive cervical cancer are expected to be diagnosed, with about 4,310 female deaths in the U.S.

According to the Global Cancer Observatory, in 2020, about 604,127 new cases of cervical cancer were diagnosed globally, and 341,831 deaths occurred in the same year due to the disease. In addition, by 2025, the incidence of cervical cancer is expected to increase to 1,495,211.

Colposcopy is a highly efficient technique for early diagnosis of lesions and selecting biopsy sites due to its high precision, adaptability, ease of use, and non-invasive approach. It further allows for a magnified evaluation of the cervix and lower genital tract for dysplastic or malignant epithelial lesions. Gynecological examinations were subjected to a time-consuming and inconvenient clinical experience for decades, including outmoded equipment and uncomfortable visits. However, there have been significant technological advancements in this field in recent years. For instance, in February 2022, an Indian gynecologist, Dr. Anupama Bhute Anand developed an integrated colposcope called SINDICOLPO, which has compatibility with Android phones.

Major market players have been adopting advanced technologies by integrating various digital platforms with colposcopy equipment. The integration is expected to introduce high-resolution imaging devices that are most likely to replace traditional colposcopes, influencing the market dynamics. Increasing awareness and adoption of preventive healthcare and disease screening programs are expected to propel market growth. For instance, in April 2021, as part of China's efforts to protect women's health, more than 120 million cervical cancer screenings were conducted for free. Improved image quality is expected to improve diagnostic precision in the early stages of cervical cancer. This can help with a faster diagnosis and treatment. Thus, the growing usage of colposcopy for diagnosing various diseases is expected to contribute to market growth.

The COVID-19 pandemic negatively impacted the market for colposcopy. A significant decline in cancer screening was witnessed globally. However, the market is expected to grow steadily during the forecast period. The WHO also aims to reduce 10% cases of cervical cancer by 2030 and prevent 70 million cases by encouraging end-users to adopt high-end technologies for early detection of the disease. This is expected to boost the market in the coming years significantly. 

Modality Insights

Based on modality, the market is segmented into optical and video segments. The optical colposcope segment dominated the market in 2022 with the largest revenue share of 68.9%. The optical colposcope is a traditional colposcope with three parts: the head, which holds the optics; the light source; and the body, which can be portable or non-portable. The adoption of the optical colposcope is high in developing countries. High affordability and low maintenance are key driving factors in this segment.

The video colposcope segment is anticipated to witness the fastest CAGR of 5.6% during the forecast period. Video modality provides visual clarity and motion pictures that help in accurate diagnosis. Video colposcopes can autofocus the image if kept 25–30 cm from the object. With video colposcopy, patients spend significantly less time in the exam room than in a conventional optical colposcopy-based exam. In addition, this system stores data, which can later be played or recalled on a screen. Thus, all these factors are expected to boost the segment growth during the forecast period.

Application Insights

In terms of application, the pelvic examination segment dominated the market in 2022 with the largest revenue share of 88.6% in 2022. This is due to the increasing cases of gynecological disorders. Colposcopy helps identify the problem more clearly when Pap smear results are abnormal. Pelvic colposcopy examinations analyze the inflammation, infection, cancerous changes, and traumatic injuries in the vagina and cervix. Due to its high negative predictive value, colposcopy is a useful cervical cancer screening method.

The oral examination segment is expected to be the fastest-growing segment during the forecast period, with a CAGR of 4.6%, owing to the increasing prevalence of premalignant lesions and oral cancers globally. The condition is fatal, and delayed treatment leads to a high morbidity rate. According to the Global Cancer Observatory, oral cavity cancer accounted for 177,757 deaths in 2020. However, oral cancer can be treated if diagnosed early. Studies suggest that a colposcope is more efficient in detecting oral lesions than other methods.

Portability Insights

The stationary colposcope segment dominated the market in 2022 with the largest revenue share of around 62%. In developing countries, where the adoption of new technology is slower, stationary colposcopes are in high demand. The market is predicted to grow due to constant technological advancements such as high-quality digital images, improved magnification, and HD camera technology. This technology has added a new variable that can be utilized for efficient diagnosis.

The handheld colposcope segment is estimated to register the fastest CAGR of 5.3% during the forecast period. The portability, ease of use, and compact nature of handheld colposcopes have increased their acceptance in smaller clinics. In addition, handheld colposcopy systems can be carried around in the hospital and to a patient’s home. It permits gynecological examinations at any location, thereby increasing access for patients. The demand for handheld colposcopes is anticipated to increase, especially in point-of-care, home care, and emergency care settings, attracting new market players.

End-use Insights

In terms of end-use, the hospital segment held the largest revenue share of 32.2% in 2022. Hospitals are well-equipped with the necessary instruments to screen the cervix to detect any precancerous and cancerous growth, thus leading to a large number of patients visiting hospitals. The rising acceptance rate for technologically advanced biopsy and the use of colposcopy for early diagnosis of cervical cancer are factors likely to drive segment growth.

The diagnostic center segment is expected to be the fastest-growing segment during the forecast period, with a CAGR of 4.7%. The growing patient population with cervical cancer allows clinicians to provide stand-alone outpatient diagnostic centers. Diagnostic centers also work to differentiate their service offerings, quality, and test accuracy by focusing on brand building through online marketing initiatives. Healthcare camps, advertising campaigns, and preventive and wellness test packages are all part of their campaigning. Thus, the aforementioned factors are contributing to segment growth.

Regional Insights

Based on region, North America dominated the market in 2022 with the largest revenue share of 31.1%, owing to an increase in the prevalence of cervical cancer and a rise in healthcare expenditure. Factors such as the adoption of colposcopy equipment, easy access to healthcare technologies, and significant distribution channels are expected to boost market growth. According to the Centers for Medicare and Medicaid Services, the U.S. government spent nearly USD 4.1 trillion on healthcare in 2020, accounting for approximately 19.7% of the total GDP.

In Asia Pacific, the market is estimated to witness the fastest CAGR of 5.1% during the forecast period owing to a large patient pool and the growing need for technologically advanced and cost-effective healthcare solutions. Furthermore, market expansion in this region is aided by increased hospitalizations and significant developments in the clinical development framework of developing economies.

Key Companies & Market Share Insights

The key players are developing advanced colposcopes to meet the growing prevalence of cervical cancer. Moreover, regional and service portfolio expansions and mergers and acquisitions are key strategies adopted by these players. For instance, in March 2023, HERhealthEQ, a social enterprise dedicated to improving women's health and well-being, expanded its partnership with Lutech Industries, Inc. (Lutech Medical), one of the world's leading manufacturers of innovative patient monitoring solutions like colposcopes. The collaboration will result in the donation of 100 Lutech Medical colposcopes.

In July 2021, DYSIS Medical Inc. announced the launch of DYSIS View. This compact and portable colposcope uses the company's cutting-edge computer-aided cervical mapping technology, aiding healthcare professionals in clearly detecting cervical abnormalities. Some prominent players in the global colposcopy market include:

• Kaps GmbH & Co. KG

• Carl Zeiss Meditec AG

• CooperSurgical, Inc

• DYSIS Medical Inc

• ATMOS Medizin Technik GmbH & Co. KG

• Olympus Corporation

• McKesson Medical-Surgical Inc.

• Ecleris

• Optomic

• Seiler Instrument Inc.

Colposcopy Market Report Scope

Global Colposcopy Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Grand View Research has segmented the global colposcopymarket report based on modality, application, portability, end-use, and region:

• Modality Outlook (Revenue, USD Million, 2017 - 2030)

  • Optical

  • Video

• Application Outlook (Revenue, USD Million, 2017 - 2030)

  • Pelvic

  • Oral

• Portability Outlook (Revenue, USD Million, 2017 - 2030)

  • Handheld

  • Stationary

• End-use Outlook (Revenue, USD Million, 2017 - 2030)

  • Hospitals

  • Diagnostic Centers

  • Gynaecology Clinic

  • Speciality Clinics

  • Ambulatory Surgical Center

  • Research and Academics

• Regional Outlook (Revenue, USD Million, 2017 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Sweden

    • Norway

    • Denmark

  • Asia Pacific

    • China

    • Japan

    • India

    • Australia

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East and Africa

    • Saudi Arabia

    • South Africa

    • UAE

    • Kuwait